Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Jun 2019
Historique:
received: 28 05 2019
revised: 22 06 2019
accepted: 23 06 2019
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication. The urinary neutrophil gelatinase-associated lipocalin (NGAL) level has been linked to tacrolimus-induced AKI in patients starting tacrolimus treatment the morning after liver transplantation. Here we tested this association using a different immunosuppression protocol: Mycophenolate mofetil administration beginning on Postoperative Day 1 and tacrolimus administration beginning on Postoperative Day 2 or 3. Urine samples were collected from 26 living donor liver transplant recipients before (Postoperative Day 1) and after (Postoperative Day 7 or 14) tacrolimus administration. NGAL levels were measured via enzyme-linked immunosorbent assays, as were those of three additional urinary biomarkers for kidney diseases: Monocyte chemotactic protein-1 (MCP-1), liver-type fatty acid-binding protein (L-FABP), and human epididymis secretory protein 4 (HE4). HE4 levels after tacrolimus administration were significantly higher in patients who developed AKI (

Identifiants

pubmed: 31242630
pii: ijms20123103
doi: 10.3390/ijms20123103
pmc: PMC6627315
pii:
doi:

Substances chimiques

Biomarkers 0
Lipocalin-2 0
WAP Four-Disulfide Core Domain Protein 2 0
WFDC2 protein, human 0
Mycophenolic Acid HU9DX48N0T
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 18H02588

Références

Biochem J. 2002 Nov 15;368(Pt 1):233-42
pubmed: 12206714
Am J Kidney Dis. 2003 Feb;41(2):269-78
pubmed: 12552488
Ren Fail. 2003 Jul;25(4):553-60
pubmed: 12911159
J Am Soc Nephrol. 2003 Oct;14(10):2534-43
pubmed: 14514731
J Clin Invest. 2005 Mar;115(3):610-21
pubmed: 15711640
Zhonghua Gan Zang Bing Za Zhi. 2005 Mar;13(3):168-70
pubmed: 15760546
Lancet. 2005 Apr 2-8;365(9466):1231-8
pubmed: 15811456
Pharmacol Ther. 2006 Oct;112(1):184-98
pubmed: 16759707
Am J Transplant. 2007 Jan;7(1):168-76
pubmed: 17109735
Liver Transpl. 2006 Dec;12(12):1755-60
pubmed: 17133564
Pediatr Nephrol. 2007 Dec;22(12):2089-95
pubmed: 17874137
Clin J Am Soc Nephrol. 2008 May;3(3):665-73
pubmed: 18337554
Ann Intern Med. 2008 Jun 3;148(11):810-9
pubmed: 18519927
Am J Transplant. 2009 Feb;9(2):327-36
pubmed: 19120077
Clin Transl Sci. 2008 Dec;1(3):200-8
pubmed: 19212447
Toxicol Sci. 2009 Jun;109(2):336-49
pubmed: 19349640
Liver Transpl. 2009 Nov;15(11):S1-34
pubmed: 19877213
Liver Transpl. 2009 Dec;15(12):1852-60
pubmed: 19938135
Nephron Clin Pract. 2010;115(2):c154-60
pubmed: 20407275
Nat Biotechnol. 2010 May;28(5):436-40
pubmed: 20458311
Nephrol Dial Transplant. 2011 May;26(5):1717-23
pubmed: 21257679
Nephrol Dial Transplant. 2011 Sep;26(9):2860-5
pubmed: 21303962
Nat Med. 2013 Feb;19(2):227-31
pubmed: 23353556
Transplant Proc. 2014 Apr;46(3):716-20
pubmed: 24767332
PLoS One. 2014 Oct 20;9(10):e110527
pubmed: 25329716
Transplant Proc. 2014 Oct;46(8):2786-9
pubmed: 25380918
Br J Anaesth. 2015 Jun;114(6):919-26
pubmed: 25673576
PLoS One. 2015 Aug 28;10(8):e0136994
pubmed: 26317775
J Clin Lab Anal. 2016 Nov;30(6):897-904
pubmed: 27075413
Clin Chim Acta. 2018 Aug;483:216-221
pubmed: 29738696
Kidney Int. 1985 Nov;28(5):767-74
pubmed: 3910916
Br J Exp Pathol. 1982 Feb;63(1):88-94
pubmed: 7066186
J Biol Chem. 1993 May 15;268(14):10425-32
pubmed: 7683678
Genomics. 1997 Oct 1;45(1):17-23
pubmed: 9339356

Auteurs

Mio Fukuda (M)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. miomio15@pharm.med.kyushu-u.ac.jp.
Department of Clinical Pharmacology and Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. miomio15@pharm.med.kyushu-u.ac.jp.

Kimitaka Suetsugu (K)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. suetsugu@pharm.med.kyushu-u.ac.jp.

Soichiro Tajima (S)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. stajima@pharm.med.kyushu-u.ac.jp.

Yurie Katsube (Y)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. katsube.yurie.170@m.kyushu-u.ac.jp.

Hiroyuki Watanabe (H)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. hirwata@pharm.med.kyushu-u.ac.jp.

Noboru Harada (N)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. nharada@surg2.med.kyushu-u.ac.jp.

Tomoharu Yoshizumi (T)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. tomyoshi@surg2.med.kyushu-u.ac.jp.

Nobuaki Egashira (N)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. n-egashi@pharm.med.kyushu-u.ac.jp.
Department of Clinical Pharmacology and Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. n-egashi@pharm.med.kyushu-u.ac.jp.

Masaki Mori (M)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. m_mori@surg2.med.kyushu-u.ac.jp.

Satohiro Masuda (S)

Department of Pharmacy, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. satomsdb@pharm.med.kyushu-u.ac.jp.
Department of Clinical Pharmacology and Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. satomsdb@pharm.med.kyushu-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH